Literature DB >> 1419776

Binding of asparaginase to mouse monocytes.

I Mori1, T Hayashi, S Kitazima, H Yamamoto.   

Abstract

We have demonstrated that biotinylated asparaginase binds to mouse monocytes. Also, asparaginase bound to peritoneal exudate, resident, splenic, bone marrow and pulmonary macrophages, but not to neutrophils or lymphocytes. Labelled asparaginase binding to peritoneal exudate macrophages was inhibited by 20-fold excess of unlabelled asparaginase. The binding of asparaginase to monocytes from mice injected with lactic dehydrogenase virus (LDV) or carrageenan was decreased. This decreased binding following treatment with LDV or carrageenan was reversed when mice were treated with diethylstilboestrol. In-vivo asparaginase clearance in mice infected with LDV was impaired as compared with that in uninfected mice. Neither strain nor age differences affected the binding to monocytes. The results suggest that the ability of asparaginase to bind to monocytes in vitro may reflect clearance function in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419776      PMCID: PMC2002013     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  12 in total

1.  IMPAIRED CLEARANCE OF ENZYMES IN MICE INFECTED WITH THE LACTIC DEHYDROGENASE AGENT.

Authors:  A L NOTKINS; C SCHEELE
Journal:  J Natl Cancer Inst       Date:  1964-10       Impact factor: 13.506

2.  Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance.

Authors:  T Hayashi; M Ozaki; I Mori; M Saito; T Itoh; H Yamamoto
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

3.  Effect of stimulation and blockade of mononuclear phagocyte system on the delayed footpad reaction to SRBC in mice.

Authors:  Y Yoshikai; S Miake; T Matsumoto; K Nomoto; K Takeya
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

4.  Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.

Authors:  L Chen; Y Suzuki; E F Wheelock
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

5.  Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha.

Authors:  J Satoh; H Seino; S Shintani; S Tanaka; T Ohteki; T Masuda; T Nobunaga; T Toyota
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

6.  Leukocyte involvement in the pathogenesis of pulmonary injury in experimental Goodpasture's syndrome.

Authors:  H Y Lan; D J Paterson; P Hutchinson; R C Atkins
Journal:  Lab Invest       Date:  1991-03       Impact factor: 5.662

7.  Regulation of enzyme levels in the blood. Influence of environmental and genetic factors on enzyme clearance.

Authors:  T Hayashi; K Salata; A Kingman; A L Notkins
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

8.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

Authors:  W J Ming; L Bersani; A Mantovani
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

9.  Functions of mononuclear phagocytes in mice exposed to diethylstilbestrol: a model of aberrant macrophage development.

Authors:  J H Dean; L D Lauer; M J Murray; M I Luster; D Neptun; D O Adams
Journal:  Cell Immunol       Date:  1986-10-15       Impact factor: 4.868

10.  Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance.

Authors:  J D BROOME
Journal:  J Exp Med       Date:  1963-07       Impact factor: 14.307

View more
  1 in total

Review 1.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.